During the ninth annual Diabetes Care Symposium, a panel of world-renowned clinicians and researchers emphasized the need to consider all aspects of diabetes over long periods of time rather than relying on short-term clinical studies, single clinical assessments of individual patients, and short-term therapeutic goals. Diabetes Care Editor in Chief Matthew C. Riddle, MD, moderated…

Four investigators will provide updates on promising areas of nonalcoholic steatohepatitis (NASH) research during a Sunday afternoon symposium. Liangyou Rui, PhD, will discuss gating NASH progression by brown adipose thermogenesis, and Ira Tabas, MD, PhD, will review novel mechanisms and therapeutic opportunities in liver fibrosis in NASH.

The ADA’s new Professional Interest Group on Eye Health will present a one-hour discussion today on “Common Questions Encountered by Diabetes Care Providers Related to Eye Issues Experienced by People with Diabetes.” Richard J. Shuldiner, OD, FAAO, FIALVS, who was named to the ADA’s Eye Health Leadership Committee earlier this year, will discuss aids that…

During the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) symposium Sunday morning at the Scientific Sessions, four presenters will discuss ongoing NIDDK initiatives related to diabetes research. Session presenters include Anna L. Gloyn, DPhil, Evren U. Azeloglu, PhD, and Jenna M. Norton, MPH.

Evidence shows that patients with type 2 diabetes can achieve remission—leaving researchers and clinicians alike wondering how best to manage patients so they can reach that goal. Four investigators, including Alison C. Barnes, RD, will examine the latest research into lifestyle interventions for type 2 diabetes remission during a two-hour symposium Sunday morning.

Three experts, including Chantal Mathieu, MD, PhD, will explore the pros and cons of using metformin, glucagon-like peptide-1 receptor agonists, and sodium-glucose co-transporter 2 inhibitors in adult patients to help lower their insulin dosage and decrease the risks associated with type 1 diabetes during a Sunday morning symposium at the Scientific Sessions.

Pancreatic islet transplantation remains an experimental therapy for patients with type 1 diabetes, but studies continue to show promising results. Sunday afternoon during the Joint ADA/Diabetes UK Symposium, four researchers will offer a snapshot of where islet transplantation stands today and offer perspective on what must happen in the future to advance the therapy. Andrew…

During a virtual symposium at the Scientific Sessions, three experts discussed challenges faced by young adults with type 1 diabetes as they make the transition from childhood to adulthood. The panelists, including Anna Floreen Sabino, MSW, CDCES, emphasized the importance of strong support systems and access to helpful resources.

During a Saturday morning presentation at the Scientific Sessions, three culinary medicine researchers will demonstrate how clinicians can improve patient outcomes through nutrition. Chef Linda Shiue, MD, will discuss how to translate culinary medicine science into solutions for type 2 diabetes prevention and management.